MARIANGEL CHAMPANG ZAMBRANO: Open Payments
NPI 1356001143 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$489 in 9 payments from 7 companies in 2025. Trend: 2023 $188 · 2024 $34 · 2025 $489
Food & beverage: $489
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 2 | $112 |
| Xeris Pharmaceuticals, Inc. | 1 | $107 |
| Eisai Inc. | 1 | $84 |
| Corcept Therapeutics | 1 | $83 |
| Tactile Systems Technology Inc | 2 | $48 |
| Acera Surgical, Inc. | 1 | $30 |
| Organogenesis Inc. | 1 | $25 |
Products named: RECORLEV, Epclusa, Leqembi, Korlym, Flexitouch Plus, Restrata Wound Matrix, AFFINITY, Livdelzi.
Industry payments across TX — which companies pay providers there.
